Carney triad

A rare syndrome involving three specific types of tumors

Carney triad is a rare syndrome characterized by the coexistence of three specific types of tumors: gastrointestinal stromal tumors (GISTs), pulmonary chondromas, and paragangliomas. This condition was first described by J. Aidan Carney in 1977.

Clinical Presentation

Diagram illustrating the components of Carney triad

Patients with Carney triad typically present with symptoms related to the individual tumors. The clinical manifestations can vary depending on the size and location of the tumors.

Gastrointestinal Stromal Tumors (GISTs)

GISTs in Carney triad are usually found in the stomach. Patients may experience abdominal pain, gastrointestinal bleeding, or a palpable abdominal mass. These tumors are often discovered incidentally during imaging studies or endoscopic procedures.

Pulmonary Chondromas

Pulmonary chondromas are benign cartilaginous tumors of the lung. They may be asymptomatic or cause respiratory symptoms such as cough, chest pain, or dyspnea. These tumors are typically detected on chest X-rays or CT scans.

Paragangliomas

Paragangliomas are neuroendocrine tumors that can occur in various locations, including the adrenal glands and along the sympathetic chain. Symptoms may include hypertension, palpitations, and headaches due to catecholamine secretion.

Pathophysiology

The exact pathophysiological mechanism underlying Carney triad is not fully understood. Unlike other syndromes involving GISTs, such as Carney-Stratakis syndrome, Carney triad is not associated with germline mutations in the succinate dehydrogenase (SDH) genes. The tumors in Carney triad are thought to arise from a common embryonic origin, but further research is needed to elucidate the genetic and molecular basis of this condition.

Diagnosis

The diagnosis of Carney triad is based on the identification of the three characteristic tumors. Imaging studies such as CT scans, MRIs, and PET scans are used to detect and evaluate the tumors. Biopsy and histopathological examination are essential for confirming the diagnosis of each tumor type.

Management

Management of Carney triad involves surgical resection of the tumors when feasible. The approach to treatment is individualized based on the size, location, and symptoms of the tumors. Regular follow-up and monitoring are important due to the potential for tumor recurrence or the development of additional tumors.

Prognosis

The prognosis for patients with Carney triad varies depending on the extent of the disease and the success of surgical interventions. While the tumors are generally benign, they can cause significant morbidity due to their size and location. Long-term follow-up is necessary to manage potential complications and monitor for new tumor development.

Related pages

• Carney complex
• Carney-Stratakis syndrome
• Gastrointestinal stromal tumor
• Paraganglioma